86 related articles for article (PubMed ID: 3872663)
1. [Changes in the ultrastructure of subcomponent C1q of human complement during spontaneous inactivation in diluted solutions].
Kozlov LV; Zinchenko AA; Sizoĭ MN; Kretova AF; Tikhonenko AS
Bioorg Khim; 1985 Jan; 11(1):37-42. PubMed ID: 3872663
[TBL] [Abstract][Full Text] [Related]
2. Electron microscopy of the complement protein C1q from the bullfrog, Rana catesbeiana.
Slayter HS; Alexander RJ; Steiner LA
Eur J Immunol; 1983 Feb; 13(2):102-6. PubMed ID: 6601008
[TBL] [Abstract][Full Text] [Related]
3. [Complement subcomponent C1q in rheumatic diseases].
Yonemasu K; Sasaki T
Ryumachi; 1986 Aug; 26(4):299-311. PubMed ID: 3551118
[No Abstract] [Full Text] [Related]
4. Interaction of C1q subcomponent with immunoglobulin M.
Kimak E; Tomaszewski JJ
Acta Biochim Pol; 1986; 33(3):179-85. PubMed ID: 2433858
[TBL] [Abstract][Full Text] [Related]
5. Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies.
Golan MD; Burger R; Loos M
J Immunol; 1982 Aug; 129(2):445-7. PubMed ID: 6177765
[TBL] [Abstract][Full Text] [Related]
6. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
7. C1q binding and C1 activation by various isolated cellular membranes.
Storrs SB; Kolb WP; Olson MS
J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
[TBL] [Abstract][Full Text] [Related]
8. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
9. A complete selective C1q deficiency in a patient with discoid lupus erythematosus (DLE).
Uenaka A; Akimoto T; Aoki T; Tsuyuguchi I; Nagaki K
Clin Exp Immunol; 1982 May; 48(2):353-8. PubMed ID: 6980744
[TBL] [Abstract][Full Text] [Related]
10. Location of the binding site in subcomponent C1q for plasma fibronectin.
Reid KB; Edmondson J
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():11-7. PubMed ID: 6610277
[TBL] [Abstract][Full Text] [Related]
11. Origin of the classical complement pathway: Lamprey orthologue of mammalian C1q acts as a lectin.
Matsushita M; Matsushita A; Endo Y; Nakata M; Kojima N; Mizuochi T; Fujita T
Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10127-31. PubMed ID: 15218103
[TBL] [Abstract][Full Text] [Related]
12. Complement and non-complement activating functions of C1q: a prototypical innate immune molecule.
Nayak A; Pednekar L; Reid KB; Kishore U
Innate Immun; 2012 Apr; 18(2):350-63. PubMed ID: 21450789
[TBL] [Abstract][Full Text] [Related]
13. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
Ying SC; Gewurz AT; Jiang H; Gewurz H
J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
[TBL] [Abstract][Full Text] [Related]
14. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
[TBL] [Abstract][Full Text] [Related]
15. [Effect of medicinal preparations on the complement: inhibition of subcomponent C1q binding to a target].
Bichucher AM; Kozlov LV
Eksp Klin Farmakol; 2007; 70(6):25-8. PubMed ID: 18318191
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal anti-mouse macrophage antibodies recognize the globular portions of C1q, a subcomponent of the first component of complement.
Heinz HP; Dlugonska H; Rüde E; Loos M
J Immunol; 1984 Jul; 133(1):400-4. PubMed ID: 6609989
[TBL] [Abstract][Full Text] [Related]
17. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
Schifferli JA; Woo P; Peters DK
Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
[TBL] [Abstract][Full Text] [Related]
19. Further evidence for dilution-dependent dissociation of C1q in human serum.
Hosoi S; Borsos T
Complement Inflamm; 1989; 6(4):259-69. PubMed ID: 2788553
[TBL] [Abstract][Full Text] [Related]
20. Chemical analysis and electron microscopy studies of human C1q prepared by different methods.
Knobel HR; Villiger W; Isliker H
Eur J Immunol; 1975 Jan; 5(1):78-82. PubMed ID: 1234048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
